MTOR and systemic sclerosis: Regarding IHC analysis of PI3K and mTOR expression in our patients affected by invasive BC and SSc, we observed a high-rate expression in overall population (55% and 45%, respectively), but PI3K over-expression was not always associated with a concomitant high mTOR expression.